Hepatitis C virus inhibitors having the general formula
are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Intermediates for the preparation of hepatitis C virus inhibitors
申请人:Bristol-Myers Squibb Company
公开号:EP2813500A1
公开(公告)日:2014-12-17
The present invention provides a compound having the formula (A)
or a salt thereof, that is useful as an intermediate for preparing compounds having anti-HCV activity.